World

Research Shows A Tiny Nanoparticle Could Have A Significant Impact On Corneal Transplant Patients

In animal models, researchers from Virginia Commonwealth University and Johns Hopkins University used a nanoparticle-encapsulated eye medication to reduce the risk of corneal graft rejection.

Corneal transplants may be the final step in restoring clear vision to many patients with eye disease. Each year, approximately 80,000 corneal transplants are performed in the United States, with over 184,000 corneal transplant surgeries performed worldwide.

The corneal graft rejection rates, however, can reach 10%. This is mostly because patients do not adhere to their prescribed treatment plans, which call for repeated applications of topical eyedrops over an extended period of time.

When patients exhibit early signs of transplanted corneal rejection, this situation becomes particularly serious. Patients who experience this need to use topical eyedrops hourly to prevent the corneal transplants from failing.

The time-consuming process of eyedrop dosage places a significant load on patients. Noncompliance with medical treatment may result in even greater graft rejection rates.

The research done by the team at Virginia Commonwealth University may improve the success rate of corneal grafts.

Patients would only need one injection shortly after the corneal transplantation operation if the nanoparticles were used to control the release of the drug over time. The nanoparticle approach reversed signs of early rejection and kept corneal grafts viable for six months.

According to the research team’s findings, when utilizing this strategy, the medicine maintains its efficacy for six months on a corneal graft rejection model.

The project’s principal investigator and an associate professor of pharmaceutics and ophthalmology at VCU School of Pharmacy, Qingguo Xu, D.Phil said, “We developed a tiny nanoparticle (around 200 nanometers) that in animal studies allows the release of the drug up to six months after a single subconjunctival injection along the eyeball”.

Also read: Never Sleep With Your Head Pointing North, Here’s Why

Spriha Rai

Recent Posts

Yemen’s Houthis Claim Responsibility For Missile Attack On Israel

Yemen's Houthis claimed responsibility for a missile attack on Israel's Negev region, targeting the Negev…

11 hours ago

From ‘Razia Sultan’ To ‘Sarfarosh’: The Timeless Journey Of Nida Fazli, ‘Main Nida’

A special screening of the film 'Main Nida', based on the life of the renowned…

12 hours ago

Flood Alert In PoK’s Muzaffarabad After Alleged Jhelum Water Release

A flood alert was issued across Muzaffarabad on Saturday after locals reported a sudden rise…

13 hours ago

Zelensky, Trump Hold Talks In Rome Ahead Of Pope’s Funeral; Discusses Ceasefire & Peace

US President Donald Trump and Ukrainian President Volodymyr Zelensky met in Rome on Saturday ahead…

14 hours ago

Pahalgam Terror Attack: Ishan Educational Institutions Organises Protest Against Terrorism

Ishan Educational Institutions, Greater Noida, today organised a peaceful protest march condemning the recent terror…

15 hours ago

Complete Ban On Drone Flights Over Noida International Airport ‘Red Zone’

Authorities have imposed a complete ban on the operation of drones and UAVs over and…

15 hours ago